New Study Finds Underweight People More Likely to Develop Dementia

Related posts:

1. Drug ads lead to better health Direct-to-consumer advertising, like those prescription drug commercials that air between your favorite shows, are actually paying off with better health outcomes for patients, according to a recently published study by Jayani Jayawardhana, an assistant professor in the College of Public Health. read more ...
2. Gene-based therapy restores cellular development and function in brain cells from people with Timothy syndrome News Release Wednesday, April 24, 2024 NIH-supported study shows potential treatment pathway for neurodevelopmental […] ...
3. Analysis compares California exchange, commercial health insurance hospital networks The suspicion that the federal Affordable Care Act reduces options for patients to choose their health care providers proves to be true, according to a new study co-authored by David Weimer, a... ...
4. Kids and codeine: Eliminating the risk, for safer pain management Leanne Patel, clinical pharmacist and Dr. Anthony Crocco, pediatric emergency physician have led a patient safety initiative at McMaster Children’s Hospital that has eliminated the use of codeine, which can be harmful for some children, in pediatric care at the hospital. For many health care providers, codeine has been somewhat of a household name in the realm of pain management. Codeine, an opioid medication available in various forms, was commonly used to treat mild to moderate pain, and could either be prescribed or purchased without a prescription in some combination products behind the pharmacy counter. In order for codeine to...
5. Diabetic Medication Helps Improve Memory Researchers at the University of Texas Medical Branch at Galveston revealed that an FDA-approved medication called rosiglitazone that is used to treat insulin resistance in diabetics also enhances learning and memory. This discovery could improve cognitive performance for those with Alzheimer’s disease. By studying genetically engineered mice designed to serve as models for Alzheimer's, “the scientists believe that the drug produced the response by reducing the negative influence of Alzheimer's on the behavior of a key brain-signaling molecule.” The molecule in question is called extracellular signal-regulated kinase (ERK). In the brains of Alzheimer's patients as well as the mice in...